FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083339580> ?p ?o ?g. }

• W2083339580 endingPage "440" @default.
• W2083339580 startingPage "431" @default.
• W2083339580 abstract "Background: Risks that are potentially associated with long-term therapies should be assessed. Objective: The present analyses were performed to determine the risk of malignancy in patients with multiple sclerosis (MS) receiving subcutaneous (sc) interferon (IFN) beta-1a, using pooled safety data from key clinical trials and data from the Merck Serono Global Drug Safety database. Methods: The standard Medical Dictionary for Regulatory Activities query “malignancies” was used to retrieve relevant cases from each data set. The incidence of malignancies per 1000 patient-years was calculated using the pooled safety data from clinical trials. The reporting rates of malignancy types were calculated for the post-marketing setting based on sales volume. Malignancies were grouped by organ localization and classified as medically confirmed or not medically confirmed according to the source of each report. The number of reported cases of each type was compared with the expected number in the general population. Results: Analysis of pooled safety data from 12 key clinical trials did not show an increased incidence of malignancy per 1000 patient-years with sc IFN beta-1a (4.0; 95% confidence interval (CI): 2.9–5.5) compared with placebo (6.4; 95% CI: 3.3–11.2). Analysis of the database shows that among the medically confirmed cases, reported to expected ratios ranged from 1 : 6 to 1 : 18 for solid tumours and from 1 : 2 to 1 : 9 for lymphohaematopoietic tumours. Conclusion: Safety data from both clinical trial and post-marketing settings suggest that treatment with sc IFN beta-1a does not increase the risk of malignancy in patients with MS." @default.
• W2083339580 created "2016-06-24" @default.
• W2083339580 creator A5008352506 @default.
• W2083339580 creator A5037409391 @default.
• W2083339580 creator A5038551021 @default.
• W2083339580 creator A5044139694 @default.
• W2083339580 creator A5057710526 @default.
• W2083339580 creator A5090856144 @default.
• W2083339580 date "2011-04-01" @default.
• W2083339580 modified "2023-09-26" @default.
• W2083339580 title "The risk of malignancy is not increased in patients with multiple sclerosis treated with subcutaneous interferon beta-1a: analysis of data from clinical trial and post-marketing surveillance settings" @default.
• W2083339580 cites W1992839581 @default.
• W2083339580 cites W2003235760 @default.
• W2083339580 cites W2005506388 @default.
• W2083339580 cites W2009890917 @default.
• W2083339580 cites W2030063800 @default.
• W2083339580 cites W2035559041 @default.
• W2083339580 cites W2036449838 @default.
• W2083339580 cites W2047876790 @default.
• W2083339580 cites W2051941539 @default.
• W2083339580 cites W2116971461 @default.
• W2083339580 cites W2117987455 @default.
• W2083339580 cites W2120791515 @default.
• W2083339580 cites W2139367012 @default.
• W2083339580 cites W2150688640 @default.
• W2083339580 cites W2168968747 @default.
• W2083339580 cites W2169098250 @default.
• W2083339580 cites W2170672646 @default.
• W2083339580 cites W2287952 @default.
• W2083339580 cites W4210548604 @default.
• W2083339580 doi "https://doi.org/10.1177/1352458511403642" @default.
• W2083339580 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21486902" @default.
• W2083339580 hasPublicationYear "2011" @default.
• W2083339580 type Work @default.
• W2083339580 sameAs 2083339580 @default.
• W2083339580 citedByCount "24" @default.
• W2083339580 countsByYear W20833395802012 @default.
• W2083339580 countsByYear W20833395802013 @default.
• W2083339580 countsByYear W20833395802014 @default.
• W2083339580 countsByYear W20833395802015 @default.
• W2083339580 countsByYear W20833395802016 @default.
• W2083339580 countsByYear W20833395802017 @default.
• W2083339580 countsByYear W20833395802018 @default.
• W2083339580 countsByYear W20833395802019 @default.
• W2083339580 countsByYear W20833395802020 @default.
• W2083339580 countsByYear W20833395802021 @default.
• W2083339580 countsByYear W20833395802023 @default.
• W2083339580 crossrefType "journal-article" @default.
• W2083339580 hasAuthorship W2083339580A5008352506 @default.
• W2083339580 hasAuthorship W2083339580A5037409391 @default.
• W2083339580 hasAuthorship W2083339580A5038551021 @default.
• W2083339580 hasAuthorship W2083339580A5044139694 @default.
• W2083339580 hasAuthorship W2083339580A5057710526 @default.
• W2083339580 hasAuthorship W2083339580A5090856144 @default.
• W2083339580 hasBestOaLocation W20833395801 @default.
• W2083339580 hasConcept C120665830 @default.
• W2083339580 hasConcept C121332964 @default.
• W2083339580 hasConcept C126322002 @default.
• W2083339580 hasConcept C142724271 @default.
• W2083339580 hasConcept C143998085 @default.
• W2083339580 hasConcept C156957248 @default.
• W2083339580 hasConcept C203014093 @default.
• W2083339580 hasConcept C204787440 @default.
• W2083339580 hasConcept C27081682 @default.
• W2083339580 hasConcept C2779399171 @default.
• W2083339580 hasConcept C2780640218 @default.
• W2083339580 hasConcept C2908647359 @default.
• W2083339580 hasConcept C2908698914 @default.
• W2083339580 hasConcept C2994247566 @default.
• W2083339580 hasConcept C44249647 @default.
• W2083339580 hasConcept C535046627 @default.
• W2083339580 hasConcept C61511704 @default.
• W2083339580 hasConcept C71924100 @default.
• W2083339580 hasConcept C99454951 @default.
• W2083339580 hasConceptScore W2083339580C120665830 @default.
• W2083339580 hasConceptScore W2083339580C121332964 @default.
• W2083339580 hasConceptScore W2083339580C126322002 @default.
• W2083339580 hasConceptScore W2083339580C142724271 @default.
• W2083339580 hasConceptScore W2083339580C143998085 @default.
• W2083339580 hasConceptScore W2083339580C156957248 @default.
• W2083339580 hasConceptScore W2083339580C203014093 @default.
• W2083339580 hasConceptScore W2083339580C204787440 @default.
• W2083339580 hasConceptScore W2083339580C27081682 @default.
• W2083339580 hasConceptScore W2083339580C2779399171 @default.
• W2083339580 hasConceptScore W2083339580C2780640218 @default.
• W2083339580 hasConceptScore W2083339580C2908647359 @default.
• W2083339580 hasConceptScore W2083339580C2908698914 @default.
• W2083339580 hasConceptScore W2083339580C2994247566 @default.
• W2083339580 hasConceptScore W2083339580C44249647 @default.
• W2083339580 hasConceptScore W2083339580C535046627 @default.
• W2083339580 hasConceptScore W2083339580C61511704 @default.
• W2083339580 hasConceptScore W2083339580C71924100 @default.
• W2083339580 hasConceptScore W2083339580C99454951 @default.
• W2083339580 hasIssue "4" @default.
• W2083339580 hasLocation W20833395801 @default.
• W2083339580 hasLocation W20833395802 @default.
• W2083339580 hasLocation W20833395803 @default.
• W2083339580 hasLocation W20833395804 @default.

• next